Survival analysis of cervical cancer patients
Abstract
Introduction. Uterine cervical cancer is the first cause of incidence and mortality in Colombian women. Nearly 10% of all the cases in the country are treated at the Instituto Nacional de Cancerología. Evaluation of the institutional success rates is suggested.Objective. Patient survival over a 5 year period was summarized for those admitted for treatment of cervical cancer at the Institute in the year 2000.
Materials and methods. All patients with cervical cancer at the Institute in 2000 were included in the survival analysis. Frequencies, central tendencies and dispersion measures were used to describe categorical and numerical variables. Survival analysis was performed by using Kaplan Meier and the multivariate Cox regression model.
Results. During the study period, 651 patients with cervical cancer were treated. Among the 455 eligible patients, 303 (66%) were alive at the end of the study period. Mean survival time for patients who did not die was 3.69 years, with a standard deviation of 2.58 years. Cumulated five year overall survival probability was 58.8% and mean survival was 4.53 years. The only variable that significantly affected the survival function was the clinical stage at the time of the diagnosis.
Conclusions. Overall survival results are similar to those described in other international institutions. If larger cohort studies were used, the power of the study can be increased in order to identify other factors associated with the prognosis.
Downloads
References
1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002 cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press; 2004.
2. República de Colombia, Sistema Nacional de Salud, Instituto Nacional de Cancerología. Normas técnicas y administrativas. Guía de implantación, detección y control de cáncer de cuello uterino. Bogotá: Imprenta Nacional; 1994.
3. República de Colombia, Ministerio de Salud. Resolución 00412 de 2000 (25 de febrero), por la cual se establecen las actividades, procedimientos e intervenciones de demanda inducida y obligatorio cumplimiento y se adoptan las normas técnicas y guías de atención para el desarrollo de las acciones de protección específica y detección temprana y la atención de enfermedades de interés en salud pública. Diario oficial No. 49.956, 31 de marzo de 2000. Bogotá D.C.: Ministerio de Salud; 2000.
4. República de Colombia, Ministerio de la Protección Social. Política nacional de salud sexual y reproductiva. Bogotá: Ministerio de la Protección Social; 2000. Fecha de consulta: 23 de octubre de 2008. Disponible en: http://www.minproteccionsocial.gov.co/vbecontent/library/documents/DocNewsNo15132DocumentNo1893.PDF.
5. Eifel P, Berek J, Markman M. Cancer of the cervix, vagina, and vulva. In: DeVita V, Hellman S, Rosenberg S, editors. Cancer principles and practice of oncology. 8th edition. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 1496-543.
6. Pérez C, Kavanagh B. Uterine cervix. In: Halperin E, Pérez C, Brady L, editors. Pérez and Brady's principles and practice of radiation oncology. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 1533-609.
7. Sankaranarayanan R, Madhukar-Budukh A, Rajkumar R. Effective screening programs for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79:954-62.
8. Instituto Nacional de Cancerología. Anuario estadístico 2004. Bogotá, D.C.: Instituto Nacional de Cancerología; 2005. Fecha de consulta: 23 de octubre de 2008. Disponible en: http://www.incancerologia.gov.co/documentos/2_9_2006_2_56_34_PM_Páginas%20interiores_total.pdf
9. Dos Santos I. Introducción al análisis de la supervivencia. En: Agencia Internacional de Investigación sobre el Cáncer. Epidemiología del cáncer: principios y métodos. Lyon, Francia: Agencia Internacional de Investigación sobre el Cáncer (IARC); 1999. p. 279-93.
10. Jensen OM, Parkin DM, Mac Lennan R, Muir CS, Skeet RG. Análisis de supervivencia. En: Registros de cáncer: principios y métodos. Publicación científica No. 95. Lyon, Francia: Agencia Internacional de Investigación sobre el Cáncer (IARC); 1995. p. 153-72.
11. Lea JS, Sheets EE, Wenham RM, Duska LR, Coleman RL, Miller DS, et al. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival. Gynecol Oncol. 2002;84:115-9.
12. Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.Cancer. 2003;97:2196-202.
13. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 6th Annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl.1):S43-103.
14. Céspedes JE, Jaramillo I, Martínez R, Olaya S, Reynales J, Uribe C, et al. Efectos de la reforma de la seguridad social en salud en Colombia sobre la equidad en el acceso y la utilización de servicios de salud. Rev Salud Pública. 2000;2:145-64.
15. Rubin P, Williams J. Carcinoma de cérvix uterino. En: Rubin P, editor. Oncología clínica: Enfoque multi-disciplinario para médicos y estudiantes. Octava edición. Madrid: Elsevier Science; 2003. p. 463-77.
16. Murphy G, Lawrencw W, Lenhard R. Oncología clínica. Manual de la American Cancer Society. Publicación científica No. 559. Washington, D.C.: Organización Panamericana de la Salud; 1996.
17. Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005;CD002225.
18. Reed N. The management of uterine sarcomas. Clin Oncol. 2008;20:470-78.
Some similar items:
- Ana María Perilla, Camilo González, Sandra Liliana Valderrama, Natasha Vanegas, Bibiana Chavarro, Luis Carlos Triana, José Roberto Támara, Carlos Arturo Álvarez, Necrotizing pneumonia by community-acquired, methicillin-resistant Staphylococcus aureus in Colombia , Biomedica: Vol. 29 No. 4 (2009)
- Yolanda Lucía López, Claudia González, Berta Natalia Gallego, Ana Lida Moreno, Stewardship of public health surveillance in the health system in Colombia: a cases study , Biomedica: Vol. 29 No. 4 (2009)
- Oscar Fernando Herrán, María F. Ardila, Categories of alcohol consumers and the criteria for classification , Biomedica: Vol. 29 No. 4 (2009)
- Ingrid Yamile Pulido, José Ramón Mantilla, Emilia María Valenzuela, María Teresa Reguero, Elsa Beatriz González, Distribution of extended spectrum β-lactamases-codifying genes in Klebsiella pneumoniae isolates from hospitals of Bogota, D.C., Colombia , Biomedica: Vol. 31 No. 1 (2011)
- Greizy López, Nancy Yaneth Gelvez, Martalucía Tamayo, Mutational frequencies in usherin (USH2A gene) in 26 Colombian individuals with Usher syndrome type II , Biomedica: Vol. 31 No. 1 (2011)
- Jhon Carlos Castaño, Fidel Ángel Núñez, María Mercedes González, Germán Téllez, María Isabel Giraldo, First case report of Mammomonogamus (Syngamus) laryngeus human infection in Colombia , Biomedica: Vol. 26 No. 3 (2006)
- Andrés F. Londoño, Silvana Levis, Juan D. Rodas, Hantavirus as important emerging agents in South America , Biomedica: Vol. 31 No. 3 (2011)
- Jefferson Antonio Buendía, Attitudes, knowledge and beliefs of patient about anti-hypertensive drugs , Biomedica: Vol. 32 No. 4 (2012)
- Mauricio Beltrán, Maritza Berrío-Pérez, María Isabel Bermúdez, Gloria Rey-Benito, Bernardo Camacho, Patricia Forero, Gloria Cristina Molina, Orlando Fals, Isabel Pisciotti, Yulieth Oliveros, Armando Cortés, Fernando De La Hoz, Absence of occult hepatitis B in Colombian blood donors , Biomedica: Vol. 31 No. 4 (2011)
- Pablo Chaparro, Edison Soto, Julio Padilla, Daniel Vargas, Estimation of the underreporting of malaria measurement in ten municipalities of the Pacific coast of Nariño during 2009 , Biomedica: Vol. 32 (2012): Suplemento 1, Malaria
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |